Galea Charles A, Han Meiling, Zhu Yan, Roberts Kade, Wang Jiping, Thompson Philip E, L Jian, Velkov Tony
Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University , Clayton, Victoria 3800, Australia.
J Nat Prod. 2017 May 26;80(5):1264-1274. doi: 10.1021/acs.jnatprod.6b00807. Epub 2017 May 2.
The increasing prevalence of polymyxin-resistant bacteria has stimulated the search for improved polymyxin lipopeptides. Here we describe the sequence and product profile for polymyxin D nonribosomal peptide synthetase from Paenibacillus polymyxa ATCC 10401. The polymyxin D synthase gene cluster comprised five genes that encoded ABC transporters (pmxC and pmxD) and enzymes responsible for the biosynthesis of polymyxin D (pmxA, pmxB, and pmxE). Unlike polymyxins B and E, polymyxin D contains d-Ser at position 3 as opposed to l-α,γ-diaminobutyric acid and has an l-Thr at position 7 rather than l-Leu. Module 3 of pmxE harbored an auxiliary epimerization domain that catalyzes the conversion of l-Ser to the d-form. Structural modeling suggested that the adenylation domains of module 3 in PmxE and modules 6 and 7 in PmxA could bind amino acids with larger side chains than their preferred substrate. Feeding individual amino acids into the culture media not only affected production of polymyxins D and D but also led to the incorporation of different amino acids at positions 3, 6, and 7 of polymyxin D. Interestingly, the unnatural polymyxin analogues did not show antibiotic activity against a panel of Gram-negative clinical isolates, while the natural polymyxins D and D exhibited excellent in vitro antibacterial activity and were efficacious against Klebsiella pneumoniae and Acinetobacter baumannii in a mouse blood infection model. The results demonstrate the excellent antibacterial activity of these unusual d-Ser polymxyins and underscore the possibility of incorporating alternate amino acids at positions 3, 6, and 7 of polymyxin D via manipulation of the polymyxin nonribosomal biosynthetic machinery.
耐多粘菌素细菌的日益流行促使人们寻找改良的多粘菌素脂肽。在此,我们描述了来自多粘芽孢杆菌ATCC 10401的多粘菌素D非核糖体肽合成酶的序列和产物概况。多粘菌素D合成酶基因簇由五个基因组成,这些基因编码ABC转运蛋白(pmxC和pmxD)以及负责多粘菌素D生物合成的酶(pmxA、pmxB和pmxE)。与多粘菌素B和E不同,多粘菌素D在第3位含有d - 丝氨酸,而非L-α,γ-二氨基丁酸,并且在第7位含有L-苏氨酸而非L-亮氨酸。pmxE的模块3含有一个辅助差向异构化结构域,可催化L-丝氨酸向d-形式的转化。结构建模表明,PmxE中模块3以及PmxA中模块6和7的腺苷化结构域可以结合比其偏好底物侧链更大的氨基酸。向培养基中添加单个氨基酸不仅影响多粘菌素D和D的产量,还导致多粘菌素D的第3、6和7位掺入不同的氨基酸。有趣的是,非天然多粘菌素类似物对一组革兰氏阴性临床分离株没有显示出抗生素活性,而天然多粘菌素D和D表现出优异的体外抗菌活性,并且在小鼠血液感染模型中对肺炎克雷伯菌和鲍曼不动杆菌有效。结果证明了这些不寻常的d-丝氨酸多粘菌素具有优异的抗菌活性,并强调了通过操纵多粘菌素非核糖体生物合成机制在多粘菌素D的第3、6和7位掺入替代氨基酸的可能性。